EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances

Magdalena M Stevanović iD, Kun Qian iD, Lin Huang, Marija Vukomanović iD

Pharmaceutics · 15.12.2025 · 17 (12) · 1613

DOI: 10.3390/pharmaceutics17121613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 15.12.2025. Verfasst von Magdalena M Stevanović und 3 weiteren Autor:innen. Beteiligte Einrichtung: Group for Biomedical Engineering and Nanobiotechnology, Institute of Technical Sciences of SASA, Kneza Mihaila 35/IV, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation (MoSTDI) of the Republic of Serbia, Slovenian Research Agency (ARRS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly (lactic-co-glycolic acid) (PLGA) is a widely used copolymer with applications across medical, pharmaceutical, and other industrial fields. Its biodegradability and biocompatibility make it one of the most versatile polymers for nanoscale drug delivery. The present review addresses current knowledge and recent advances in PLGA-based co-delivery nanoformulations with a special reference to design strategies, functional mechanisms, and translational potential. Conventional and advanced fabrication methods, the structural design of PLGA-based nanocarriers, approaches to scale-up and reproducibility, classification of co-delivery types, mechanisms governing drug release, surface modification and functionalization are all discussed. Special attention is given to PLGA-based co-delivery systems, encompassing drug–drug, drug–gene, gene–gene and multi-modal combinations, supported by recent studies demonstrating synergistic therapeutic outcomes. The review also examines clinical translation efforts and the regulatory landscape for PLGA-based nanocarriers. Unlike most existing reviews that typically focus either on PLGA fundamentals or on co-delivery approaches in isolation, this article bridges these domains by providing an integrated, comparative analysis of PLGA-based co-delivery systems and elucidating a critical gap in linking design strategies with translational requirements. In addition, by emphasising the relevance of PLGA-based co-delivery for combination therapies, particularly in cancer and other complex diseases, the review highlights the strong clinical and translational potential of these platforms. Key challenges, such as reproducibility, large-scale manufacturing, and complex regulatory pathways, are discussed alongside emerging trends and future perspectives. Taken together, this review positions PLGA-based co-delivery strategies as a critical driver for advancing precision therapeutics and shaping the future landscape of nanomedicine.

Schlagwörter

Stichwörter der Autor:innen

classification of co-delivery typesclinical translation and regulatory considerationsdrug releasefabrication and modificationnanoparticles

Autor:innen und Institutionen

  • Group for Biomedical Engineering and Nanobiotechnology, Institute of Technical Sciences of SASA, Kneza Mihaila 35/IV, 11000 Belgrade, Serbia.
  • State Key Laboratory for Oncogenes and Related Genes, School of Biomedical Engineering, Institute of Medical Robotics, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Advanced Materials Department, Jozef Stefan Institute, Jamova 39, 1000 Ljubljana, Slovenia.

ORCID-Profile: Magdalena M Stevanović, Kun Qian, Marija Vukomanović

Förderung

  • Ministry of Science, Technological Development and Innovation (MoSTDI) of the Republic of Serbia
  • Slovenian Research Agency (ARRS)

Zitieren

APA

Stevanović, M. M., Qian, K., Huang, L., & Vukomanović, M. (2025). PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances. Pharmaceutics, 17(12), 1613. https://doi.org/10.3390/pharmaceutics17121613

Vancouver

Stevanović MM, Qian K, Huang L, Vukomanović M. PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances. Pharmaceutics. 2025;17(12):1613. doi:10.3390/pharmaceutics17121613

BibTeX
@article{Stevanovi2025,
  author = {Stevanović, Magdalena M and Qian, Kun and Huang, Lin and Vukomanović, Marija},
  title = {PLGA-Based Co-Delivery Nanoformulations: Overview, Strategies, and Recent Advances},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {1613},
  doi = {10.3390/pharmaceutics17121613}
}
Kostenlos starten →